Oxford BioMedica accelerates viral vector development and manufacture
(Alliance News) - Oxford Biomedica PLC on Monday announced the launch of fast-track offering for adeno-associated viral vectors and lentiviral vector platforms. Read More
| Price | 563.00p on 13-04-2026 at 10:40:13 |
|---|---|
| Change | -3.00p -0.53% |
| Buy | 565.00p |
| Sell | 562.00p |
| Last Trade: | Sell 8.00 at 563.00p |
| Day's Volume: | 40,135 |
| Last Close: | 566.00p |
| Open: | 575.00p |
| ISIN: | GB00BDFBVT43 |
| Day's Range | 559.00p - 575.00p |
| 52wk Range: | 270.50p - 950.00p |
| Market Capitalisation: | £680.66m |
| VWAP: | 563.30892p |
| Shares in Issue: | 120.90m |
Oxford Biomedica (OXB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 8 | 563.00p | Automatic Execution |
11:37:39 - 13-Apr-26 |
| Sell* | 9 | 563.00p | Automatic Execution |
11:37:39 - 13-Apr-26 |
| Sell* | 40 | 563.00p | Automatic Execution |
11:37:39 - 13-Apr-26 |
| Unknown* | 0 | 566.00p | SI Trade |
11:24:57 - 13-Apr-26 |
| Buy* | 1 | 566.00p | Automatic Execution |
11:24:03 - 13-Apr-26 |
| Unknown* | 0 | 566.00p | SI Trade |
11:22:05 - 13-Apr-26 |
| Sell* | 1 | 563.00p | Automatic Execution |
11:16:33 - 13-Apr-26 |
| Sell* | 19 | 563.00p | Automatic Execution |
11:16:33 - 13-Apr-26 |
| Sell* | 16 | 563.00p | Automatic Execution |
11:16:33 - 13-Apr-26 |
| Sell* | 1,000 | 563.00p | SI Trade |
11:16:32 - 13-Apr-26 |
Oxford Biomedica (OXB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Apr 2026 5:18 pm | RNS | Grant of Awards |
| 1st Apr 2026 7:00 am | RNS | Total Voting Rights |
| 30th Mar 2026 3:30 pm | RNS | 2026 Annual General Meeting notification |
| 26th Mar 2026 7:00 am | RNS | Preliminary results for the year ended 31 Dec 2025 |
| 18th Mar 2026 7:00 am | RNS-R | Licensing agreement with VVMF |
| 9th Mar 2026 7:53 am | RNS | Admission to Trading |
| 4th Mar 2026 11:45 am | RNS | Admission to Trading Application |
| 3rd Mar 2026 7:00 am | RNS | Capital Markets Day and investor conferences |
| 2nd Mar 2026 7:00 am | RNS | Total Voting Rights |
| 27th Feb 2026 1:31 pm | RNS | Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica |